MUSECHEM: YOUR PARTNER IN DRUG DISCOVERY AND DEVELOPMENT

The MAPK/ERK signaling pathway is an additional important target for inhibitors. Inhibitors targeting MAPK/ERK are used in cancer cells treatments to protect against unchecked cell proliferation and tumor development.Antibiotics are a part of inhibitors that have actually transformed the management of bacterial infections. By targeting bacterial ce